Phase IV adaptive randomised clinical trials evaluating efficacy and cost-efficacy of pre-emptive pharmacogenetic genotyping strategies in the Spanish National Health System: iPHARMGx Master Protocol and PREVESTATGx nested clinical trial
评估西班牙国家卫生系统中预防性药物遗传基因分型策略的疗效和成本效益的IV期适应性随机临床试验:iPHARMGx主方案和PREVESTATGx嵌套临床试验
期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2024-089823
Stewart, Stefan; Seco-Meseguer, Enrique; Diago-Sempere, Elena; Marín-Candón, Alicia; Carmona, Montserrat; Estébanez, Miriam; López-Fernández, Luis A; Imaz-Iglesia, Iñaki; Del Mar García Saiz, María; Laserna-Mendieta, Emilio J; Peiró, Ana M; Farré, Magí; Rodriguez-Jimenez, Consuelo; Saiz-Rodriguez, Miriam; Sanabria-Cabrera, Judith; Rosas-Alonso, Rocío; Abad-Santos, Francisco; Pedrosa, Lucia; Carcas, Antonio J; García García, Irene; Borobia, Alberto M